Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.

about

Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.

Item

http://www.wikidata.org/entity/Q47877989

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pleural effusion and molecular ...... fe Italian multicenter series.

@en

Pleural effusion and molecular ...... fe Italian multicenter series.

@nl

type

Item

label

Pleural effusion and molecular ...... fe Italian multicenter series.

@en

Pleural effusion and molecular ...... fe Italian multicenter series.

@nl

prefLabel

Pleural effusion and molecular ...... fe Italian multicenter series.

@en

Pleural effusion and molecular ...... fe Italian multicenter series.

@nl

P1476

Pleural effusion and molecular ...... fe Italian multicenter series.

@en

P2093

Agostino Cortelezzi

http://www.w3.org/2001/XMLSchema#string

Antonella Gozzini

http://www.w3.org/2001/XMLSchema#string

Cristina Bucelli

http://www.w3.org/2001/XMLSchema#string

Daniele Cattaneo

http://www.w3.org/2001/XMLSchema#string

Dario Ferrero

http://www.w3.org/2001/XMLSchema#string

Ester Maria Orlandi

http://www.w3.org/2001/XMLSchema#string

Ester Pungolino

http://www.w3.org/2001/XMLSchema#string

Fabio Stagno

http://www.w3.org/2001/XMLSchema#string

Fabrizio Pane

http://www.w3.org/2001/XMLSchema#string

Federica Sorà

http://www.w3.org/2001/XMLSchema#string

P2860

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

Cancer statistics, 2010

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib.

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate.

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet.

P304

95-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-017-3144-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28971265

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia